Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 11, 2007 - Issue 10
Submit an article Journal homepage
169
Views
19
CrossRef citations to date
0
Altmetric
Review

Interleukin-18: a pro-inflammatory cytokine that plays an important role in acute pancreatitis

Bo-Si Yuan Department of Gastroenterology, Clinical School of Nanjing, Southern Medical University, Jinling Hospital, Nanjing, Jiangsu Province, China +86 25 80860127; [email protected]
,
Ren-Min Zhu Department of Gastroenterology, Clinical School of Nanjing, Southern Medical University, Jinling Hospital, Nanjing, Jiangsu Province, China +86 25 80860127; [email protected]
,
Martin Braddock Discovery Bioscience, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, LE11 5RH, Leicestershire, UK
,
Xiao-Hua Zhang Department of Gastroenterology, Clinical School of Nanjing, Southern Medical University, Jinling Hospital, Nanjing, Jiangsu Province, China +86 25 80860127; [email protected]
,
Wei Shi Department of Gastroenterology, Clinical School of Nanjing, Southern Medical University, Jinling Hospital, Nanjing, Jiangsu Province, China +86 25 80860127; [email protected]
&
Ming-Hua Zheng Department of Infection and Liver Diseases, The First Affi liated Hospital of Wenzhou Medical College, No.2 Fuxue Lane, Wenzhou, Zhejiang, China
Pages 1261-1271 | Published online: 02 Oct 2007

Bibliography

  • GHAYUR T, BANERJEE S, HUGUNIN M et al.: Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature (1997) 386:619-623.
  • OKAMURA H, TSUTSI H, KOMATSU T et al.: Cloning of a new cytokine that induces IFN-γ production by T cells. Nature (1995) 378:88-91.
  • BORASCHI D, DINARELLO CA: IL-18 in autoimmunity: review. Eur. Cytokine Netw. (2006) 17:224-252.
  • USHIO S, NAMBA M, OKURA T et al.: Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J. Immunol. (1996) 156:4274-4279.
  • KOHNO K, KATAOKA J, OHTSUKI T et al.: IFN-γ-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J. Immunol. (1997) 158:1541-1550.
  • ROBINSON D, SHIBUYA K, MUI A et al.: IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NF-κB. Immunity (1997) 7:571-581.
  • YOSHIMOTO T, TAKEDA K, TANAKA T et al.: IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-γ production. J. Immunol. (1998) 161:3400-3407.
  • DAO T, OHASHI K, KAYANO T, KURIMOTO M, OKAMURA H: Interferon-γ-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell Immunol. (1996) 173:230-235.
  • TSUTSUI H, NAKANISHI K, MATSUI K et al.: IFN-γ-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J. Immunol. (1996) 157:3967-3973.
  • DAI SM, SHAN ZZ DR, XU H, NISHIOKA K: Cellular targets of interleukin-18 in rheumatoid arthritis. Ann. Rheum. Dis. (2007) (In Press).
  • SIVALINGAM SP, THUMBOO J, VASOO S, FONG KY: HLA-DRB1*04 gene polymorphisms and expressions profiles of interleukin-18 and interleukin-18 binding protein following in vitro stimulation in human peripheral blood mononuclear cells of healthy individuals and patients with rheumatoid arthritis. Life Sci. (2007) 80:1887-1896.
  • JOHN T, KOHL B, MOBASHERI A, ERTEL W, SHAKIBAEI M: Interleukin-18 induces apoptosis in human articular chondrocytes. Histol. Histopathol. (2007) 22:469-482.
  • SIVALINGAM SP, THUMBOO J, VASOO S, THIO ST, TSE C, FONG KY: In vivo pro- and anti-inflammatory cytokines in normal and patients with rheumatoid arthritis. Ann. Acad. Med. Singapore (2007) 36:96-99.
  • CHEN DY, LAN JL, LIN FJ, HSIEH TY: Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease. Arthritis Rheum. (2005) 53:320-327.
  • CHEN DY, LAN JL, LIN FJ, HSIEH TY: Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. J. Rheumatol. (2004) 31:2189-2198.
  • LOTITO AP, CAMPA A, SILVA CA, KISS MH, MELLO SB: Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis. J. Rheumatol. (2007) 34:823-830.
  • MIRANDA LA, FISCHER RG, SZTAJNBOK FR, JOHANSSON A, FIGUEREDO CM, GUSTAFSSON A: Increased interleukin-18 in patients with juvenile idiopathic arthritis and early attachment loss. J. Periodontol. (2005) 76:75-82.
  • HULTHE J, MCPHEAT W, SAMNEGARD A, TORNVALL P, HAMSTEN A, ERIKSSON P: Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6. Atherosclerosis (2006) 188:450-454.
  • PETERSEN AM, PENKOWA M, IVERSEN M et al.: Elevated levels of IL-18 in plasma and skeletal muscle in chronic obstructive pulmonary disease. Lung (2007) 185:161-171.
  • HOSHINO T, KATO S, OKA N et al.: Pulmonary inflammation and emphysema: role of the cytokines IL-18 and IL-13. Am. J. Respir. Crit. Care Med. (2007) 176:49-62.
  • LEE KS, KIM SR, PARK SJ et al.: Antioxidant down-regulates interleukin-18 expression in asthma. Mol. Pharmacol. (2006) 70:1184-1193.
  • SHIN HD, KIM LH, PARK BL et al.: Association of interleukin 18 (IL18) polymorphisms with specific IgE levels to mite allergens among asthmatic patients. Allergy (2005) 60:900-906.
  • LUDWICZEK O, KASER A, NOVICK D, DINARELLO CA, RUBINSTEIN M, TILG H: Elevated systemic levels of free interleukin-18 (IL-18) in patients with Crohn's disease. Eur. Cytokine Netw. (2005) 16:27-33.
  • TAMURA K, FUKUDA Y, SASHIO H et al.: IL18 polymorphism is associated with an increased risk of Crohn's disease. J. Gastroenterol. (2002) 37(Suppl.):111-116.
  • WIERCINSKA-DRAPALO A, FLISIAK R, JAROSZEWICZ J, PROKOPOWICZ D: Plasma interleukin-18 reflects severity of ulcerative colitis. World J. Gastroenterol. (2005) 11:605-608.
  • TAKEUCHI D, YOSHIDOME H, KATO A et al.: Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice. Hepatology (2004) 39:699-710.
  • FALASCA K, UCCIFERRI C, DALESSANDRO M et al.: Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. Ann. Clin. Lab. Sci. (2006) 36:144-150.
  • VECCHIET J, FALASCA K, CACCIATORE P et al.: Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C virus infection and non-alcoholic fatty liver disease. Ann. Clin. Lab. Sci. (2005) 35:415-422.
  • HOMSI E, JANINO P, DE FARIA JB: Role of caspases on cell death, inflammation, and cell cycle in glycerol-induced acute renal failure. Kidney Int. (2006) 70:1666.
  • FAUBEL S, LEWIS EC, REZNIKOV L: Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1β, IL-18, IL-6, and neutrophil infiltration in the kidney. J. Pharmacol. Exp. Ther. (2007) 322:8-15.
  • TSCHOEKE SK, OBERHOLZER A, MOLDAWER LL: Interleukin-18: a novel prognostic cytokine in bacteria-induced sepsis. Crit. Care Med. (2006) 34:1225-1233.
  • TOOULI J, BROOKE-SMITH M, BASSI C et al.: Working party of the program commitee of the Bangkok world congress of gastroenterology 2002. Guidelines for the management of acute pancreatitis. J. Gastroenterol. Hepatol. (2002) 17(Suppl.):S15-S39.
  • DINARELLO CA: Interleukin-18 and the pathogenesis of inflammatory diseases. Semin. Nephrol. (2007) 27:98-114.
  • TORIGOE K, USHIO S, OKURA T et al.: Purification and characterization of the human interleukin-18 receptor. J. Biol. Chem. (1997) 272:25737-25742.
  • THOMASSEN E, BIRD TA, RENSHAW BR, KENNEDY MK, SIMS JE: Binding of interleukin-18 to the interleukin-1 receptor homologous receptor IL-1Rrp1 leads to activation of signaling pathways similar to those used by interleukin-1. J. Interferon Cytokine Res. (1998) 18:1077-1088.
  • BORN TL, THOMASSEN E, BIRD TA, SIMS JE: Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J. Biol. Chem. (1998) 273:29445-29450.
  • ADACHI O, KAWAI T, TAKEDA K et al.: Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity (1998) 9:143-150.
  • TAKEDA K, KAISHO T, AKIRA S: Toll-like receptors. Annu. Rev. Immunol. (2003) 21:335-376.
  • SUZUKI N, SUZUKI S, DUNCAN GS et al.: Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature (2002) 416:750-756.
  • WANG C, DENG L, HONG M, AKKARAJU GR, INOUE J, CHEN ZJ: TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature (2001) 412:346-351.
  • DENG L, WANG C, SPENCER E et al.: Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell (2000) 103:351-361.
  • WERESZCZYNSKA-SIEMIATKOWSKA U, MROCZKO B, SIEMIATKOWSKI A: Serum profiles of interleukin-18 in different severity forms of human acute pancreatitis. Scand. J. Gastroenterol. (2002) 37:1097-1102.
  • UEDA T, TAKEYAMA Y, YASUDA T et al.: Significant elevation of serum interleukin-18 levels in patients with acute pancreatitis. J. Gastroenterol. (2006) 41:158-165.
  • RAU B, BAUMGART K, PASZKOWSKI AS, MAYER JM, BEGER HG: Clinical relevance of caspase-1 activated cytokines in acute pancreatitis: high correlation of serum interleukin-18 with pancreatic necrosis and systemic complications. Crit. Care Med. (2001) 29:1556-1562.
  • PEREIASLOV AA, CHUKLIN SM, POSIVNYCH MM: Pathogenesis and treatment of haemocoagulation disorders in acute necrotic pancreatitis. Klinicheskaia Khirurhiia (2006) 10:26-29.
  • WORKING PARTY OF THE BRITISH SOCIETY OF GASTROENTEROLOGY; ASSOCIATION OF SURGEONS OF GREAT BRITAIN AND IRELAND; PANCREATIC SOCIETY OF GREAT BRITAIN AND IRELAND; ASSOCIATION OF UPPER GI SURGEONS OF GREAT BRITAIN AND IRELAND: UK guidelines for the management of acute pancreatitis. Gut (2005) 54(Suppl. 3):1-9.
  • TALAMINI G, UOMO G, PEZZILLI R et al.: Serum creatinine and chest radiographs in the early assessment of acute pancreatitis. Am. J. Surg. (1999) 177:7-14.
  • PEZZILLI R, FANTINI L, MORSELLI-LABATE AM: New approaches for the treatment of acute pancreatitis. J. Pancreas (2006) 7:79-91.
  • PEZZILLI R, BILLI P, MINIERO R et al.: Serum interleukin-6, interleukin-8, and β2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Dig. Dis. Sci. (1995) 40:2341-2348.
  • TRINCHIERI G: Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. (1995) 13:251-276.
  • ROBINSON D, SHIBUYA K, MUI A et al.: IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NF-κB. Immunity (1997) 7:571-581.
  • PEZZILLI R, MINIERO R, CAPPELLETTI O, BARAKAT B: Behavior of serum interleukin 12 in human acute pancreatitis. Pancreas (1999) 18:247-251.
  • FIRESTEIN GS, ALVARO-GARCIA JM, MAKI R: Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J. Immunol. (1990) 144:3347-3353.
  • FELDMANN M, BRENNAN FM, MAINI RN: Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. (1996) 14:397-440.
  • DINARELLO CA: Interleukin-18, a proinflammatory cytokine. Eur. Cytokine Netw. (2000) 11:483-486.
  • RAU BM, KRUGER CM, SCHILLING MK: Anti-cytokine strategies in acute pancreatitis: pathophysiological insights and clinical implications. Rocz Akad. Med. Bialymst. (2005) 50:106-115.
  • PUREN AJ, FANTUZZI G, GU Y, SU MS, DINARELLO CA: Interleukin-18 (IFNγ-inducing factor) induces IL-8 and IL-1β via TNF-α production from non-CD14+ human blood mononuclear cells. J. Clin. Invest. (1998) 101:711-721.
  • ENDO S, INOUE Y, FUJINO Y, WAKABAYASHI G, INADA K, SATO S: Interleukin 18 levels reflect the severity of acute pancreatitis. Res. Commun. Mol. Pathol. Pharmacol. (2001) 110:285-291.
  • RAU B, POCH B, GANSAUGE F et al.: Pathophysiologic role of oxygen free radicals in acute pancreatitis: initiating event or mediator of tissue damage? Ann. Surg. (2000) 231:352-360.
  • WERESZCZYNSKA-SIEMIATKOWSKA, DABROWSKI A, JEDYNAK M, GABRYELEWICZ A: Oxidative stress as an early prognostic factor in acute pancreatitis (AP): its correlation with serum phospholipase A2 (PLA2) and plasma polymorphonuclear elastase (PMN-E) in different-severity forms of human AP. Pancreas (1998) 17:163-168.
  • WERESZCZYNSKA-SIEMIATKOWSKA U, DABROWSKI A, SIEMIATKOWSKI A, MROCZKO B, LASZEWICZ W, GABRYELEWICZ A: Serum profiles of E-selectin, interleukin-10, and interleukin-6 and oxidative stress parameters in patients with acute pancreatitis and nonpancreatic acute abdominal pain. Pancreas (2003) 26:144-152.
  • BRAGANZA JM, SCOTT P, BILTON D et al.: Evidence for early oxidative stress in acute pancreatitis. Clues for correction. Int. J. Pancreatol. (1995) 17:69-81.
  • RAYMAN MP: The importance of selenium to human health. Lancet (2000) 356:233-241.
  • SCHULZ HU, PAGE L, HALANGK W, LIPPERT H: Plasma lipid peroxide and selenium levels in acute pancreatitis. 1st Combined Meeting of the European Pancreatic Club and the International Association of Pancreatology. Mannheim, Germany (12 – 15 June 1996). Digestion (1996) 57:215-283 (Abstract).
  • SZUSTER-CIESIELSKA A, DANILUK J, KANDEFER-SZERSZEN M: Oxidative stress in blood of patients with alcohol-related pancreatitis. Pancreas (2001) 22:261-266.
  • VIEDMA CONTRERAS JA: Leukocyte activation markers in clinical practice. Clin. Chem. Lab. Med. (1999) 37:607-622.
  • FROSSARD JL, HADENGUE A, PASTOR CM: New serum markers for the detection of severe acute pancreatitis in humans. Am. J. Respir. Crit. Care Med. (2001) 164:162-170.
  • WERESZCZYNSKA-SIEMIATKOWSKA U, MROCZKO B, SIEMIATKOWSKI A, SZMITKOWSKI M, BORAWSKA M, KOSEL J: The importance of interleukin 18, glutathione peroxidase, and selenium concentration changes in acute pancreatitis. Dig. Dis. Sci. (2004) 49:642-650.
  • SHIBATA M, HIROTA M, NOZAWA F, OKABE A, KURIMOTO M, OGAWA M: Increased concentrations of plasma IL-18 in patients with hepatic dysfunction after hepatectomy. Cytokine (2000) 12:1526-1530.
  • SHIBATA M, HIROTA M, INOUE K, OGAWA M: Contribution of IL-18 and its related cytokines on the development of hepatic dysfunction in non-biliary acute pancreatitis. Int. Congress Series (2003) 1255:159-165.
  • NISHIOKA T, KUROISHI T, SUGAWARA Y et al.: Induction of serum IL-18 with Propionibacterium acnes and lipopolysaccharide in phagocytic macrophage-inactivated mice. J. Leukoc. Biol. (2007) (In Press).
  • TSUTSUI H, MATSUI K, KAWADA N et al.: IL-18 accounts for both TNF-α- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J. Immunol. (1997) 159:3961-3967.
  • TSUTSUI H, MATSUI K, OKAMURA H, NAKANISHI K: Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol. Rev. (2000) 174:192-209.
  • FINOTTO S, SIEBLER J, HAUSDING M et al.: Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo. Gut (2004) 53:1058.
  • TAKEUCHI D, YOSHIDOME H, KATO A et al.: Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice. Hepatology (2004) 39:699-710.
  • FAUBEL S, EDELSTEIN CL: Caspases as drug targets in ischemic organ injury. Curr. Drug Targets Immune Endocr. Metabol. Disord. (2005) 5:269-287.
  • TAKEYAMA Y, HORI Y, TAKASE K, UEDA T, YAMAMOTO M, KURODA Y: Apoptotic cell death of hepatocytes in rat experimental severe acute pancreatitis. Surgery (2000) 127:55-64.
  • HORI Y, TAKEYAMA Y, UEDA T, SHINKAI M, TAKASE K, KURODA Y: Macrophage-derived transforming growth factor-β1 induces hepatocellular injury via apoptosis in rat severe acute pancreatitis. Surgery (2000) 127:641-649.
  • KRAMS SM, EGAWA H, QUINN MB, VILLANUEVA JC, GARCIA-KENNEDY R, MARTINEZ OM: Apoptosis as a mechanism of cell death in liver allograft rejection. Transplantation (1995) 59:621-625.
  • UEDA T, TAKEYAMA Y, TAKASE K, HORI Y, KURODA Y, HO HS: Hematin is one of the cytotoxic factors in pancreatitis-associated ascitic fluid that causes hepatocellular injury. Surgery (2002) 131:66-74.
  • YUMOTO E, HIGASHI T, NOUSO K et al.: Serum γ-interferon-inducing factor (IL-18) and IL-10 levels in patients with acute hepatitis and fulminant hepatic failure. J. Gastroenterol. Hepatol. (2002) 17:285-294.
  • BLINDENBACHER A, WANG X, LANGER I et al.: Interleukin 6 is important for survival after partial hepatectomy in mice. Hepatology (2003) 38:674-682.
  • MARINO E, CARDIER JE: Differential effect of IL-18 on endothelial cell apoptosis mediated by TNF-α and Fas (CD95). Cytokine (2003) 22:142-148.
  • SIVALINGAM SP, THUMBOO J, VASOO S, FONG KY: HLA-DRB1*04 gene polymorphisms and expressions profiles of interleukin-18 and interleukin-18 binding protein following in vitro stimulation in human peripheral blood mononuclear cells of healthy individuals and patients with rheumatoid arthritis. Life Sci. (2007) 80:1887-1896.
  • SMEETS RL, VAN DE LOO FA, ARNTZ OJ et al.: Adenoviral delivery of IL-18 binding protein C ameliorates collagen-induced arthritis in mice. Gene Ther. (2003) 10:1004-1011.
  • BANDA NK, VONDRACEK A, KRAUS D et al.: Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein. J. Immunol. (2003) 170:2100-2105.
  • PLATER-ZYBERK C, JOOSTEN LA, HELSEN MM et al.: Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J. Clin. Invest. (2001) 108:1825-1832.
  • WILDBAUM G, YOUSSEF S, GRABIE N, KARIN N: Neutralizing antibodies to IFN-γ-inducing factor prevent experimental autoimmune encephalomyelitis. J. Immunol. (1998) 161:6368-6374.
  • IM SH, BARCHAN D, MAITI PK, RAVEH L, SOUROUJON MC, FUCHS S: Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18. FASEB J. (2001) 15:2140-2148.
  • SOUROUJON MC, MAITI PK, FEFERMAN T, IM SH, RAVEH L, FUCHS S: Suppression of myasthenia gravis by antigen-specific mucosal tolerance and modulation of cytokines and costimulatory factors. Ann. NY Acad. Sci. (2003) 998:533-536.
  • PISKIN G, TURSEN U, SYLVA-STEENLAND RM, BOS JD, TEUNISSEN MB: Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-γ inducers – IL-12, IL-18 and IL-23. Exp. Dermatol. (2004) 13:764-772.
  • NUMEROF RP, DINARELLO CA, ASADULLAH K: Cytokines as potential therapeutic targets for inflammatory skin diseases. Eur. Cytokine Netw. (2005) 16:101-103.
  • NUMEROF RP, ASADULLAH K: Cytokine and anti-cytokine therapies for psoriasis and atopic dermatitis. Biodrugs (2006) 20:93-103.
  • BOSS P, NEUMANN D, DEL GIUDICE E et al.: IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease. Proc. Natl. Acad. Sci. USA (2003) 100:14181-14186.
  • NOLD M, HAUSER IA, HOFLER S et al.: IL-18BPa:Fc cooperates with immunosuppressive drugs in human whole blood. Biochem. Pharmacol. (2003) 66:505-510.
  • NICOLETTI F, DI MARCO R, PAPACCIO G et al.: Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct. Eur. J. Immunol. (2003) 33:2278-2286.
  • ZACCONE P, PHILLIPS J, CONGET I, COOKE A, NICOLETTI F: IL-18 binding protein fusion construct delays the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse. Clin. Immunol. (2005) 115:74-79.
  • FAGGIONI R, JONES-CARSON J, REED DA et al.: Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of TNF-α and IL-18. Proc. Natl. Acad. Sci. USA (2000) 97:2367-2372.
  • FANTUZZI G, BANDA NK, GUTHRIDGE C et al.: Generation and characterization of mice transgenic for human IL-18-binding protein isoform A. J. Leuk. Biol. (2003) 74:889-896.
  • NETEA MG, FANTUZZI G, KULLBERG BJ et al.: Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia. J. Immunol. (2000) 164:2644-2649.
  • MELNIKOV VY, ECDER T, FANTUZZI G et al.: Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J. Clin. Invest. (2001) 107:1145-1152.
  • RAEBURN CD, DINARELLO CA, ZIMMERMAN MA et al.: Neutralization of IL-18 attenuates lipopolysaccharide-induced myocardial dysfunction. Am. J. Physiol. Heart Circ. Physiol. (2002) 283:650-657.
  • RAU B, ZHUANG Y, SCHOELER C, HANS J, TILTON B, SCHILLING M: Caspase-1 activated cytokines in experimental acute pancreatitis: synergistic effects of IL-1β and IL-18 on the development of disease severity. Pancreas (2003) 27:403-404.
  • PERREGAUX DG, MCNIFF P, LALIBERTE R et al.: Identification and characterization of a novel class of interleukin-1 post-translational processing inhibitors. J. Pharmacol. Exp. Ther. (2001) 299:187-197.
  • BAXTER A, BENT J, BOWERS K et al.: Hit-to-lead studies: the discovery of potent adamantane amide P2X7 receptor antagonists. Bioorg. Med. Chem. Lett. (2003) 13:4047-4050.
  • ALCARAZ L, BAXTER A, BENT J et al.: Novel P2X7 receptor antagonists. Bioorg. Med. Chem. Lett. (2003) 13:4043-4046.
  • HONORE P, DONNELLY-ROBERTS D, NAMOVIC MT et al.: A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J. Pharmacol. Exp. Ther. (2006) 319:1376-1385.
  • STOKES L, JIANG LH, ALCARAZ L et al.: Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373. Br. J. Pharmacol. (2006) 149:880-887.
  • BUCHANAN MS, CARROLL AR, ADDEPALLI R, AVERY VM, HOOPER JN, QUINN RJ: Natural products, stylissadines A and B, specific antagonists of the P2X7 receptor, an important inflammatory target. J. Org. Chem. (2007) 72:2309-2317.
  • MEHTA VB, HART J, WEWERS MD: ATP-stimulated release of interleukin (IL)-1β and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage. J. Biol. Chem. (2001) 276:3820-3826.
  • ZHANG XH, ZHU RM, XU WA, WAN HJ, LU H: Therapeutic effects of caspase-1 inhibitors on acute lung injury in experimental severe acute pancreatitis. World J. Gastroenterol. (2007) 13:623-627.
  • NORMAN J, YANG J, FINK G et al.: Severity and mortality of experimental pancreatitis are dependent on interleukin-1 converting enzyme (ICE). J. Interferon Cytokine Res. (1997) 17:113-118.
  • RAU B, PASZKOWSKI A, LILLICH S, BAUMGART K, MOLLER P, BEGER HG: Differential effects of caspase-1/interleukin-1β-converting enzyme on acinar cell necrosis and apoptosis in severe acute experimental pancreatitis. Lab. Invest. (2001) 81:1001-1013.
  • PASZKOWSKI AS, RAU B, MAYER JM, MOLLER P, BEGER HG: Therapeutic application of caspase 1/interleukin-1β-converting enzyme inhibitor decreases the death rate in severe acute experimental pancreatitis. Ann. Surg. (2002) 235:68-76.
  • NORMAN J, FRANZ M,MESSINA J: Interleukin-1 receptor antagonism decreases severity of experimental acute pancreatitis. Surgery (1995) 117:648-655.
  • NORMAN JG, FRANZ MG, FINK GS: Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann. Surg. (1995) 221:625-631.
  • MAYER J, RAU B, GANSAUGE F, BEGER HG: Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut (2000) 47:546-552.
  • OBERHOLZER A, FEILNER A, HENTZE H et al.: Sepsis after severe injury interrupts caspase-dependent processing of interleukin-18. J. Trauma (2000) 49:11-16.
  • SUGAWARA S, UEHARA A, NOCHI T et al.: Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J. Immunol. (2001) 167:6568-6575.
  • PIRHONEN J, SARENEVA T, JULKUNEN I, MATIKAINEN S: Virus infection induces proteolytic processing of IL-18 in human macrophages via caspase-1 and caspase-3 activation. Eur. J. Immunol. (2001) 31:726-733.
  • KORKMAZ B, HAJJAR E, KALUPOV T et al.: Influence of charge distribution at the active site surface on the substrate specificity of human neutrophil protease 3 and elastase. A kinetic and molecular modeling analysis. J. Biol. Chem. (2007) 282:1989-1997.
  • IKAWA K, NISHIOKA T, YU Z et al.: Involvement of neutrophil recruitment and protease-activated receptor 2 activation in the induction of IL-18 in mice. J. Leuk. Biol. (2005) 78:1118-1126.
  • DINARELLO CA, FANTUZZI G: Interleukin-18 and host defense against infection. J. Infect. Dis. (2003) 187(Suppl. 2):S370-S384.
  • TAKEDA K, TSUTSUI H, YOSHIMOTO T et al.: Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity (1998) 8:383-390.
  • LOGAN TF, ROBERTSON MJ: Interleukins 18 and 21: biology, mechanisms of action, toxicity, and clinical activity. Curr. Oncol. Rep. (2006) 8:114-119.
  • HWANG KS, CHO WK, YOO J et al.: Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity. Cancer Gene Ther. (2004) 11:397-407.
  • GOLAB J, STOKLOSA T: Technology evaluation: SB-485232, GlaxoSmithKline. Curr. Opin. Mol. Ther. (2005) 7:85-93.
  • DUMONT FJ: The interleukin-1 families of cytokines and receptors: therapeutic potential for immunomodulation and the treatment of inflammatory disorders. Expert Opin. Ther. Patents (2006) 16:879-912.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.